Ocular Hypertension Market is driven by early diagnosis demand
  Ocular hypertension management primarily involves the use of pressure‐lowering pharmaceuticals, advanced diagnostic devices, and combination therapies designed to prevent the progression to glaucoma. Key products include topical prostaglandin analogs, beta blockers, alpha agonists, and carbonic anhydrase inhibitors, often administered via innovative sustained‐release formulations....
0 Comentários 0 Compartilhamentos 85 Visualizações 0 Anterior